首页> 中文期刊> 《湖南中医药大学学报》 >晕清降压方对代谢性高血压部分代谢组分的影响

晕清降压方对代谢性高血压部分代谢组分的影响

         

摘要

Objective To observe the effect Yunqing Jiangya Prescription on part metabolic components of metabolic hypertension, and investigate the mechanism of its depressurization. Methods The 90 cases of patients with metabolic hypertension were randomly divided into observation group with 60 patients and control group with 30 patients. The control group was received with the basic treatment of Western medicine while observation group was treated with Yun-qing Jiangya Prescription. After 4 weeks, the change of blood lipids, BUA and blood pressure before and after treatment were analyzed statistically. Results The observation group was better than control group in improving metabolic disorders, with sta-tistical significance (P<0.05). While in depressurization, the observation group and control group had no statistical significance (P>0.05). Conclusion Yunqing Jiangya Prescription shows the depressurization effect, and it could improve the part metabolite components of metabolic hypertension. Its mechanism of depressurization is probably related with improving the abnor-mal metabolite components, recovering vascular compliance and reducing vascular resistance.%目的:观察晕清降压方对代谢性高血压部分组分的影响,并探讨其降压的作用机制。方法将90例代谢性高血压患者随机分为观察组60例、对照组30例。对照组:西医基础治疗;观察组:晕清降压方治疗。于4周后统计分析两组患者治疗前后血脂、血尿酸、血压的变化。结果观察组在改善代谢紊乱优于对照组,差异有统计学意义(P<0.05),观察组在降压上与对照组相比,差异无统计学意义(P>0.05)。结论晕清降压方在降低血压的同时,可有效改善代谢性高血压部分代谢组分,其降低血压的机制可能与改善其代谢异常组分,减轻代谢异常成分对血管造成的损害,恢复血管顺应性,降低血管阻力有关。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号